- Diabetic retinopathy screening
- Treatment of Diabetic Retinopathy
- Quality of Life for patients with diabetic retinopathy
- Imaging of the Eye
Memberships
- Member of the Royal College of Ophthalmologists
- Fellow of the Royal College of Physicians
- UK Diabetes Research Network (DRN) Clinical Studies Advisory Group
- European Vision Institute, Clinical Trials, Site of Excellence (EVI.CT.SE)
- Diabetic Retinopathy Subcommittee of the European EVI.CT.SE Retina Specialists
- Gloucestershire Countywide R & D Consortium
- Programme Director for the Diabetic Retinopathy Programme in England (since 1st August 2002, prior to introduction in 2003).
- Consultant Ophthalmologist, Gloucestershire Eye Unit, Cheltenham General Hospital (since 2nd October 2006)
- Director of the Gloucestershire Diabetic Eye Screening Service (since 1st October 1998)
- Consultant Ophthalmologist, Oxford Eye Hospital, substantive since 1st August 2007
- Senior Research Fellow and Tutor in Medicine, Harris Manchester College, University of Oxford
- Tutor to the Speciality Doctor Group (SAS) at Gloucestershire Hospitals NHS Financial Trust
- Honorary Associate Professor, University of Warwick Medical School
- Organiser of a successful 4 Nations DR Research Group, leading to a DRN Writing Group
- Organiser of a successful European Conference in May 2009 in Oxford – the European Association for the Study of Diabetic Eye Complications (EASDec)
Peter Scanlon |
Research Group
Gloucestershire Diabetic Retinopathy Research Group
[more information]
Contact
Gloucestershire Hospitals NHS Foundation Trust
Cheltenham General Hospital
Sandford Road
GL53 7AN
Cheltenham, Gloucestershire
United Kingdom
Phone: (44) 08454 222 851
Fax: (44) 08454 223 853
E-mail:
peter.scanlon[at]glos.nhs.uk
Key Publications
- Sallam A, Scanlon PH, Stratton IM, Jones V, Martin CN, Brelen M and Johnston RL
Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy.
Diabetic Medicine 2011. E-pub ahead of print. - Scanlon PH
Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy.
Eye (Lond) 2010. 24(3): 435-440 - Taylor DJ, Goatman KA, Gregory A, Histed MG, Martin CN, Warburton TJ and Scanlon PH
Image quality standardisation for diabetic retinopathy screening.
Expert Review of Ophthalmology 2009. 4(5):469-476 - Scanlon PH, Carter S, Foy C, Husband R, Abbas J and Bachmann MO
Diabetic retinopathy and socio-economic deprivation in Gloucestershire.
J Med Screen 2008. 15(3):118-21 - Scanlon PH, Foy C and Chen FK
Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
Br J Ophthalmol 2008. 92(6):775-8 - Scanlon PH
The English national screening programme for sight-threatening retinopathy.
J Med Screen 2008. 15(1):1-4 - Scanlon PH, Martin ML, Bailey C, Johnston E, Hykin P and Keightley S
Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy.
Diabetic Medicine 2006. 23(1): 60-6. - Scanlon PH, Foy C, Malhotra R and Aldington SJ
The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening.
Diabetes Care 2005. 28(10):2448-53. - Scanlon PH, Carter S, Foy C, Ratiram D and Harney B
An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.
Br J Ophthalmol 2005 89(8):971-5. - Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N, Harney B, Aldington SJ
The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy.
Diabetic Medicine 2003. 20 (6), 467-474.
Research Groups
People